Free Trial

LogicMark (LGMK) Competitors

LogicMark logo
$0.0054 +0.00 (+5.88%)
As of 08/1/2025 03:59 PM Eastern

LGMK vs. SINT, STRR, STSS, NDRA, QNRX, CHEK, HSCS, BLAC, XAGE, and AMIX

Should you be buying LogicMark stock or one of its competitors? The main competitors of LogicMark include Sintx Technologies (SINT), Star Equity (STRR), Sharps Technology (STSS), ENDRA Life Sciences (NDRA), Quoin Pharmaceuticals (QNRX), Check-Cap (CHEK), HeartSciences (HSCS), Bellevue Life Sciences Acquisition (BLAC), Longevity Health (XAGE), and Autonomix Medical (AMIX). These companies are all part of the "medical equipment" industry.

LogicMark vs. Its Competitors

LogicMark (NASDAQ:LGMK) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

In the previous week, LogicMark and LogicMark both had 1 articles in the media. LogicMark's average media sentiment score of 1.99 beat Sintx Technologies' score of 0.00 indicating that LogicMark is being referred to more favorably in the media.

Company Overall Sentiment
LogicMark Very Positive
Sintx Technologies Neutral

LogicMark has a net margin of -141.96% compared to Sintx Technologies' net margin of -483.85%. LogicMark's return on equity of -124.91% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
LogicMark-141.96% -124.91% -92.05%
Sintx Technologies -483.85%-203.66%-104.76%

LogicMark has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500.

7.9% of LogicMark shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 2.2% of LogicMark shares are held by company insiders. Comparatively, 0.0% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Sintx Technologies has lower revenue, but higher earnings than LogicMark. Sintx Technologies is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LogicMark$9.88M0.31-$14.55M-$223.500.00
Sintx Technologies$2.89M2.08-$11.02M-$50.56-0.05

Sintx Technologies has a consensus target price of $28.00, suggesting a potential upside of 1,066.67%. Given Sintx Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than LogicMark.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LogicMark
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Sintx Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

LogicMark beats Sintx Technologies on 8 of the 15 factors compared between the two stocks.

Get LogicMark News Delivered to You Automatically

Sign up to receive the latest news and ratings for LGMK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LGMK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LGMK vs. The Competition

MetricLogicMarkSurgical appliances & supplies IndustryIndustrials SectorNASDAQ Exchange
Market Cap$2.94M$24.02M$7.61B$9.53B
Dividend YieldN/AN/A4.56%4.08%
P/E Ratio0.0013.0525.2223.80
Price / Sales0.311.7198.7888.08
Price / CashN/A12.8027.7657.96
Price / Book0.001.614.345.55
Net Income-$14.55M-$5.31M$792.92M$259.03M
7 Day PerformanceN/A-8.79%-1.85%-4.56%
1 Month PerformanceN/A-10.61%2.34%4.49%
1 Year PerformanceN/A-22.23%29.40%18.05%

LogicMark Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LGMK
LogicMark
0.6589 of 5 stars
$0.01
+5.9%
N/A-100.0%$2.94M$9.88M0.0020Positive News
Gap Up
SINT
Sintx Technologies
2.0089 of 5 stars
$2.78
-0.7%
$28.00
+907.2%
-50.3%$7.02M$1.23M-0.0540Upcoming Earnings
Short Interest ↑
STRR
Star Equity
3.1691 of 5 stars
$2.09
-0.5%
$5.00
+139.2%
-55.5%$6.77M$53.36M-0.61460Positive News
High Trading Volume
STSS
Sharps Technology
0.8015 of 5 stars
$6.03
-1.5%
N/AN/A$6.24MN/A0.003Positive News
Gap Down
NDRA
ENDRA Life Sciences
1.4328 of 5 stars
$6.35
-3.8%
$50.00
+687.4%
-99.9%$4.97MN/A-0.0420Positive News
Short Interest ↑
Gap Down
QNRX
Quoin Pharmaceuticals
1.7019 of 5 stars
$8.16
-0.1%
N/A-67.0%$4.81MN/A-0.174News Coverage
Positive News
CHEK
Check-Cap
N/A$0.75
-1.6%
N/A-66.1%$4.45MN/A-0.2580Positive News
HSCS
HeartSciences
2.2695 of 5 stars
$3.54
-10.2%
$13.00
+267.2%
-21.6%$4.26MN/A-0.3810News Coverage
Upcoming Earnings
BLAC
Bellevue Life Sciences Acquisition
N/A$0.98
+2.1%
N/A-93.6%$3.96MN/A0.00N/AGap Up
High Trading Volume
XAGE
Longevity Health
N/A$3.91
+0.8%
N/AN/A$3.90M$50K0.0014News Coverage
AMIX
Autonomix Medical
3.1288 of 5 stars
$1.31
-5.8%
$16.50
+1,159.5%
-93.3%$3.87MN/A-0.181Gap Down

Related Companies and Tools


This page (NASDAQ:LGMK) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners